Healthcare Industry News:  Balloon catheter 

Devices Interventional

 News Release - February 28, 2008

Hatch Medical to Broker Chronic Total Occlusion Device

DULUTH, Ga.--(HSMN NewsFeed)--Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has recently entered into an agreement with Medical Miracles (Leeds, UK) to broker its patented and CE Marked chronic total occlusion (CTO) device, POLAR™.

POLAR™ (Path Of Least Arterial Resistance) is a mechanical device that generates reciprocal and lateral movements at the distal end of standard guidewires with frequencies of 16 to 100 Hz. when passed through an angioplasty Balloon catheter, allowing clinicians to confidently cross occluded vessels.

Percutaneous interventions (PI) of a CTO remains one of the more difficult technical challenges for interventional practitioners, despite the progress made in the field of PI in the past decade. It has been estimated that CTOs are found in one-third of patients with significant vascular disease. Failure to revascularize a CTO often leaves the patient with either the more invasive option of bypass graft surgery or continuing medical therapy, which may or may not control their symptoms; neither is optimal.

In several published clinical studies which utilize the POLAR™ device in a technique known as “vibrational angioplasty”, the device has proven to be both expedient and efficacious. In one such study, seventy-eight patients with chronic total occlusions (>3 months) that were resistant to conventional techniques were treated with the POLAR™ device using a variety of standard guidewires. The study found that lesions were successfully crossed in 67 (85.9%) of these cases and antegrade flow was re-established in 59 (75.5%) patients, causing one of the study participants to conclude, “The outcomes with this low-cost device have been favorable.”

“We are pleased to be working with Medical Miracles’ POLAR™ device and believe that it provides an efficacious and cost-effective solution to this chronic clinical challenge,” commented Paul Gianneschi, Managing Principal of Hatch Medical, L.L.C.

Barry Kaye, CEO of Medical Miracles added, “We are excited to be working with Hatch Medical, as they have a long-standing history of successfully representing companies through the license or sale of complex medical technologies.”

The POLAR™ device is available for licensing or acquisition to interested third parties through an exclusive agreement with Hatch Medical.

For additional information on this, or other Hatch Medical, L.L.C. products and services, e-mail the company at This release and additional news about Hatch Medical can be obtained by visiting the company’s web site at:

Source: Hatch Medical

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.